Mar 4, 2021 | Securities Class Action Archive
Ontrak, Inc. Investors Who Have Suffered Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Ontrak, Inc. (“Ontrak” or the “Company”) (NASDAQ: OTRK) to determine whether the Company engaged in securities fraud or other unlawful business practices.
On March 3, 2021, a class action lawsuit was filed in United States District Court, Central District of California, on behalf of Ontrak investors who purchased, or otherwise acquired Ontrak securities between November 5, 2020 and February 26, 2021, both dates inclusive (the “Class Period”).
According to the class action complaint, throughout the Class Period, the Ontrak Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.
The Ontrak Defendants, according to the class action complaint, failed to disclose to investors (1) that Ontrak’s largest customer evaluated the Company on a provider basis, valuing Ontrak’s performance based on achieving the lowest cost per medical visit rather than clinical outcomes or medical cost savings; (2) as a result, Ontrak’s largest customer did not find the Company’s program to be effective and was reasonably likely to terminate its contract with Ontrak; (3) because this customer accounted for a significant portion of the Company’s revenue, the loss of the customer would have an outsized impact on Ontrak’s financial results; and (4) as a result of the foregoing, the Ontrak Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, OTRK SECURITIES DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, BUSINESS DEVELOPMENT, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Mar 2, 2021 | Securities Class Action Archive
Class Action Investigation On Behalf Of VLDR Investors Who Have Suffered Losses Greater Than $100,000
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Velodyne Lidar, Inc. (“Velodyne” or the “Company”) (NASDAQ: VLDR) to determine whether the Company engaged in securities fraud or other unlawful business practices.
A class action lawsuit has been filed in United States District Court, Northern District of California, on behalf of investors who purchased, or otherwise acquired, Velodyne securities between November 9, 2020 and February 19, 2021 (the “Class Period”).
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, VELODYNE SECURITIES DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $100,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, BUSINESS DEVELOPMENT, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
According to the class action complaint, throughout the Class Period, the Velodyne Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. According to the complaint, the Velodyne Defendants failed to disclose to investors that (1) certain of Velodyne’s directors had failed to operate with respect, honesty, integrity, and candor in their dealings with the Company’s officers and directors; (2) the Company was investigating the foregoing matters; and (3) as a result of the foregoing, the Velodyne Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.
Mar 1, 2021 | Securities Class Action Archive
Class Action Investigation On Behalf Of ATNX Investors Who Have Suffered Losses Greater Than $50,000
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX) to determine whether the Company engaged in securities fraud or other unlawful business practices.
Shares of Athenex dropped significantly after the Company reported Q4 results and received a complete response letter from the FDA expressing concerns about the Company’s new drug application for a drug which treats metastatic breast cancer.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, ATNX SECURITIES AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, BUSINESS DEVELOPMENT, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Feb 22, 2021 | Securities Class Action Archive
Ebix Investors Who Have Suffered Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Ebix, Inc. (“Ebix” or the “Company”) (NASDAQ: EBIX) to determine whether the Company engaged in securities fraud or other unlawful business practices.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, EBIX SECURITIES AND SUFFERED LOSSES GREATER THAN $100,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, BUSINESS DEVELOPMENT, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
On February 19, 2021, Ebix announced that “[b]y letter dated February 15, 2021, RSM US LLP (‘RSM’) notified the Audit Committee of the Board of Directors (the ‘Audit Committee’) of Ebix, Inc. . . . of its resignation as the Company’s independent registered public accounting firm.”
According to Ebix, “. . . RSM told the Chairman of the Company’s Audit Committee during a telephone call that RSM was resigning as the Company’s independent registered public accounting firm, effective immediately. RSM then advised the Chairman on the call that it was resigning as a result of being unable, despite repeated inquiries, to obtain sufficient appropriate audit evidence that would allow it to evaluate the business purpose of significant unusual transactions that occurred in the fourth quarter of 2020, including whether such transactions have been properly accounted for and disclosed in the financial statements subject to the Audit.” Ebix also reported that “RSM informed the Chairman that the unusual transactions concerned the Company’s gift card business in India.”
On this news, Ebix shares fell by as much as 27% during after-hours trading on February 19, 2021, thereby injuring Ebix investors.
Feb 19, 2021 | Securities Class Action Archive
Class Action Lawsuit Filed On Behalf Of Investors Of Immunovant, Inc., f/k/a Health Sciences Acquisitions Corporation, – IMVT Investors With Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.
On February 19, 2021, a class action lawsuit was filed on behalf of investors of Immunovant, Inc., f/k/a Health Sciences Acquisitions Corporation, (“Immunovant” or the “Company”) (NASDAQ: IMVT) who purchased, or otherwise acquired IMVT securities between October 2, 2019 and February 1, 2021, both dates inclusive (the “Class Period).
According to the class action complaint, throughout the Class Period, the Immunovant Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies.
The Immunovant Defendants, according to the class action complaint, made false and/or misleading statements and/or failed to disclose that: (i) HSAC had performed inadequate due diligence into Legacy Immunovant prior to the Merger, and/or ignored or failed to disclose safety issues associated with IMVT-1401; (ii) IMVT-1401 was less safe than the Company had led investors to believe, particularly with respect to treating TED and WAIHA; (iii) the foregoing foreseeably diminished IMVT-1401’s prospects for regulatory approval, commercial viability, and profitability; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, IMMUNOVANT SECURITIES DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $100,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, BUSINESS DEVELOPMENT, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Feb 18, 2021 | Securities Class Action Archive
Investigation of Zoom Video Communications, Inc. Officers And Directors For Potential Breach of Fiduciary Duty Claims – Zoom Investors Who Have Held Their Stock Continuously Since 2019 Are Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating whether certain officers and/or directors of Zoom Video Communications, Inc. (“Zoom” or the “Company”) (NASDAQ: ZM) breached their fiduciary duties to Zoom and the Company’s shareholders.
The breach of fiduciary duties investigation concerns, among other things, whether certain officers and/or directors of Zoom made false and/or misleading statements about the Company’s business, operational, and compliance policies regarding, for example, the level of security protecting Zoom’s video conferencing services.
If you have held Zoom stock continuously since 2019 and wish to discuss Kehoe Law Firm’s investigation or have questions about your potential legal rights, please contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], [email protected], to learn more about the investigation or potential legal claims.
